Authors:
Simonart, T
Simonart, JM
Derdelinckx, I
De Dobbeleer, G
Verleysen, A
Verraes, S
de Maubeuge, J
Van Vooren, JP
Naeyaert, JM
de la Brassine, M
Peetermans, WE
Heenen, M
Citation: T. Simonart et al., Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis, CLIN INF D, 32(1), 2001, pp. E9-E12
Authors:
Simonart, T
Degraef, C
Mosselmans, R
Hermans, P
Lunardi-Iskandar, Y
Noel, JC
Van Vooren, JP
Parent, D
Heenen, M
Galand, P
Citation: T. Simonart et al., Early- and late-stage Kaposi's sarcoma-derived cells but not activated endothelial cells can invade de-epidermized dermis, J INVES DER, 116(5), 2001, pp. 679-685
Authors:
Tanghe, A
Content, J
Van Vooren, JP
Portaels, F
Huygen, K
Citation: A. Tanghe et al., Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer, INFEC IMMUN, 69(9), 2001, pp. 5403-5411
Authors:
Zlotta, AR
Van Vooren, JP
Huygen, K
Drowart, A
Decock, M
Pirson, M
Jurion, F
Palfliet, K
Denis, O
Simon, J
Schulman, CC
Citation: Ar. Zlotta et al., What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?, EUR UROL, 37(4), 2000, pp. 470-477
Citation: T. Simonart et Jp. Van Vooren, Long latency of human herpesvirus type 8 infection and the appearance of classic Kaposi's sarcoma - Reply, J AM ACAD D, 43(4), 2000, pp. 732-732
Authors:
Simonart, T
Degraef, C
Andrei, G
Mosselmans, R
Hermans, P
Van Vooren, JP
Noel, JC
Boelaert, JR
Snoeck, R
Heenen, M
Citation: T. Simonart et al., Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors, J INVES DER, 115(5), 2000, pp. 893-900
Authors:
Zlotta, AR
Van Vooren, JP
Denis, O
Drowart, A
Daffe, M
Lefevre, P
Schandene, L
De Cock, M
De Bruyn, J
Vandenbussche, P
Jurion, F
Palfliet, K
Simon, J
Schulman, CC
Content, J
Huygen, K
Citation: Ar. Zlotta et al., What are the immunologically active components of Bacille Calmette-Guerin in therapy of superficial bladder cancer?, INT J CANC, 87(6), 2000, pp. 844-852
Authors:
Simonart, T
Hermans, P
Schandene, L
Van Vooren, JP
Citation: T. Simonart et al., Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature, BR J DERM, 143(3), 2000, pp. 557-563
Authors:
Delforge, ML
Farber, CM
De Leener, F
Caroyer, JM
Liesnard, C
Van Vooren, JP
Citation: Ml. Delforge et al., Foscarnet activity on human immunodeficiency virus type 1 in the central nervous system, CLIN INF D, 28(4), 1999, pp. 931-931
Authors:
Simonart, T
Andrei, G
Parent, D
Van Vooren, JP
De Clercq, E
Snoeck, R
Citation: T. Simonart et al., In vitro sensitivity of Kaposi's sarcoma cells to various chemotherapeuticagents including acyclic nucleoside phosphonates, ANTIVIR CHE, 10(3), 1999, pp. 129-134
Authors:
De Thier, F
Simonart, T
Hermans, P
Andre, J
Van Vooren, JP
Noel, JC
Citation: F. De Thier et al., Early- and late-stage Kaposi's sarcoma lesions exhibit similar proliferation fraction, AM J DERMAT, 21(1), 1999, pp. 25-27
Authors:
Simonart, T
Noel, JC
Van Vooren, JP
De Dobbeleer, G
Citation: T. Simonart et al., Classic Kaposi's sarcoma after multiple-partner heterosexual behavior in Central Africa, J AM ACAD D, 41(4), 1999, pp. 648-649
Authors:
Zlotta, AR
Noel, JC
Fayt, I
Drowart, A
Van Vooren, JP
Huygen, K
Simon, J
Schulman, CC
Citation: Ar. Zlotta et al., Correlation and prognostic significance of p53, A21(WAF1/CIP1) and Ki-67 expression in patients with superficial bladder tumors treated with bacillusCalmette-Guerin intravesical therapy, J UROL, 161(3), 1999, pp. 792-798
Authors:
Simonart, T
Hermans, P
Van Vooren, JP
Meuris, S
Citation: T. Simonart et al., Paradoxical pro-Kaposi's sarcoma activity of preparations of human chorionic gonadotropin, BLOOD, 94(1), 1999, pp. 376-377
Authors:
Colardijn, F
Damas, P
De Mol, P
Glupczynski, Y
Gordus, B
Ronveaux, O
Struelens, M
Thys, JP
Verhaegen, J
Vogelaers, D
Wilmotte, L
Bossens, M
Byl, B
Carpentier, M
Claeys, G
Crokaert, F
Daux, J
Dediste, A
De Jongh, D
Delporte, JP
Desmet, F
d'Hollander, A
Ezzedine, H
Fameree, D
Garrino, M
Goossens, H
Govaerts, D
Hecq, JD
Ieven, G
Jacobs, F
Jordens, P
Larbuisson, W
Laterre, PF
Lauwers, S
Lefebure, B
Lievin, V
Meert, P
Melin, P
Mertens, A
Moulin, D
Peetermans, W
Peleman, R
Potvliege, C
Reynaert, M
Rost, F
Simon, A
Sion, JP
Stuyck, J
Valcke, Y
Van Beek, F
Vandercam, B
Van Laethem, Y
Van Landuyt, H
Van Vooren, JP
Van Wyngaarden, E
Verbist, L
Verschraegen, G
Vincent, JL
Wauters, G
Willems, L
Citation: F. Colardijn et al., GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistantbacteria in hospitals, ACT CLIN B, 54(1), 1999, pp. 15-16